In the present study we evaluated B-cell subsets and their functional development in 74 newborns from birth to 6 months of life. Moreover, we evaluated "natural antibody" production in vitro. The results documented a predominance of naive B-lymphocytes at all time-points evaluated, decreasing from birth to 6 months (p=O.009). The percentages of CD27+IgD+ and CD27+IgDne g memory B-cells were very low at birth and significantly increased only at 6 months (p=O.02 and p<O.OOl, respectively). We found a significant increase only in in vitro stimulated IgG production at 6 months as compared to birth (p<O.OOl). Moreover, a lower secretion of anti-Pn IgM antibodies up to 6 months of age, as compared to controls was observed. Our results underline that the susceptibility and severe course of infection in the neonate can be attributed, at least in part, to the lack of pre-existing immunological memory and competent adaptive immunity.
In the present study we evaluated B-cell subsets and their functional development in 74 newborns from birth to 6 months of life. Moreover, we evaluated "natural antibody" production in vitro. The results documented a predominance of naive B-lymphocytes at all time-points evaluated, decreasing from birth to 6 months (p=O.009). The percentages of CD27+IgD+ and CD27+IgDne g memory B-cells were very low at birth and significantly increased only at 6 months (p=O.02 and p<O.OOl, respectively). We found a significant increase only in in vitro stimulated IgG production at 6 months as compared to birth (p<O.OOl). Moreover, a lower secretion of anti-Pn IgM antibodies up to 6 months of age, as compared to controls was observed. Our results underline that the susceptibility and severe course of infection in the neonate can be attributed, at least in part, to the lack of pre-existing immunological memory and competent adaptive immunity.
The immaturity of neonatal immune response has been widely reported (1) (2) (3) (4) ; compared to adults, many components of the immune system do not function well in infants. Neonate immune responses are directed against a limited number of antigens; also antibody production is largely of the IgM isotype and of low affinity. The inability to mount an efficient antibody response to antigenic challenge suggests the immaturity of different elements of the immune system at birth (5) (6) . Neonate T lymphocytes show a naive cell surface phenotype with a corresponding naive functional program. Differential expression of costimulatory molecules on neonatal lymphocytes has been reported. CD40 expression on neonatal B cells is equivalent to adult B-Iymphocytes, but expression of CD40L on activated neonate T cells is decreased (7) (8) (9) . The low production of IgG by B-cells from healthy neonates has been reported as a function of a quantitative deficiency of memory B-Iymphocytes (10) . It is well-known that mature function can be achieved by all arms of the adaptive immune system with time. An increasing body of evidence indicates that the neonatal period of life is a unique developmental stage in which responses are highly plastic and dependent on the conditions of antigen exposure (11) . Therefore, part of this deficiency may be related to a lack of previous exposure to antigens. During the development of B cell maturation, it is possible to distinguish functionally different subsets and distinct stages of maturation by using CD27 as a memory B-cell marker (12) (13) (14) : CD27 neg IgD+ (naive B cells), which do not secrete sizeable levels of immunoglobulins; CD27+IgD+ which mostly secrete IgM; and CD27+IgDne g which comprise IgGand IgA-producing cells. Several studies on human peripheral B cells revealed that a large population of memory B-cells corresponds to circulating analogues of splenic marginal zone B cells that secrete, polyreactive "natural antibodies" (13, (15) (16) (17) (18) . These "natural antibodies" are mostly ofthe IgM isotype, are polyspecific and can bind to a particular antigen or pathogen, even if the host has never been exposed to that antigen (1, 5, (19) (20) . Although the specific function of these antibodies has not been demonstrated directly, it is generally assumed that they are part of the innate immune system and delay pathogen replication until the developing acquired humoral and cellular immune response can clear the infection.
In this study we evaluated B cell subsets and the development of functional B cell activity in newborns followed from birth to 6 months of life. For this purpose we analysed B cell surface antigen expression and in vitro immunoglobulin production. Moreover, since accumulating evidence indicates that B cell subpopulations with innate-like immune functions can play an additional role in defence, we also evaluated in vitro "natural antibody" production.
MATERIALS AND METHODS'

Subjects
Seventy-four healthy neonates (35 male and 39 female; 15 caesarean section (21%) and 59 (79%) vaginal deliveries) born at the Neonatology Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy were consecutively enrolled in the study. All newborns were full-term ( gestational age ;:0: 37 weeks) and birth-weight was> 2,500 gr.
A small amount of peripheral blood was obtained at birth (within the first 5 days of life), and at 1, 3 and 6 months, from the discarded remains of routine blood tests. The small sample quantities sometimes did not allow to carry out all the evaluations.
Twenty-two older children (9 males and 13 females) median age 8 years (range 3-15 years) admitted to the Hospital to draw blood samples for different reasons but without any evidence of infection or immunological disorders were utilized as a control group. Written informed consent was obtained from at least one parent for all neonates and children. The Ethical Committee of the Fondazione IRCCS Policlinico S.Matteo approved the study.
Cell Isolation and phenotyping
Peripheral blood mononuclear cells (PBMCs) were isolated using the standard Ficoll-Hipaque (Lymphoprep, Nycomed Pharma AS, Oslo, Norway) gradient method. Expression of surface antigens on PBMCs was evaluated by direct immunofluorescence, in a two-or threecolour analysis, on a FACSCanto flow cytometer (BD Biosciences, Mountain View, CA).
Anti-CD45-FITC and anti-CDl9-PE/CD20-PerCP monoclonal antibodies (BD Biosciences) were used to calculate B-cell percentages on CD45+gatedlymphocytes. Anti-CD20-PerCP, anti-CD27-FITC and anti-IgD-PE (BD Biosciences) were used to identify the percentage of B-Iymphocyte subsets at different stages of maturation. Appropriate isotype-matched controls were included. Data were calculated using FACSDiva software (BD Biosciences).
In vitro Ig production
Spontaneous and polyclonally-stimulated in vitro Ig production was evaluated in PBMCs using a previously described method (21) . Briefly, PBMCs (l05/well) were cultured, alone or in the presence of2.5xI0 4/well irradiated (70 Gy) CDw32 L cells (LGC Promochem, Teddington, UK), 0.5 ug/ml of anti-CD40 mAb (Calbiochem, Merck KGaA, Darmstadt, Germany), and 200 ng/ml recombinant human interieukin-IO (rhIL-IO, R&D Systems Inc, Minneapolis, MN). All cultures were plated with Iscove's medium, supplemented with 5 ug/ml bovine insulin, 0.5% bovine serum albumin, 2 ug/ml ethanolamine, 20 mM hepes buffer (all from Sigma-Aldrich Corporation, St Louis, MO), 50 ug/ml gentamycin, 2 mM L-glutamine and 5% heat inactivated fetal bovine serum (all from Gibco, Life Technologies Ltd, Paisley, UK). All experiments were run in triplicate at a final volume of 200 Ill/well. The supernatants were harvested after 10-day incubation at 37°C in humidified 5% CO 2 ,
Supernatant IgG, IgA, IgM quantification
IgG, IgA and IgM concentrations in the supernatant were determined by an ELISA technique, as previously described (21) . Briefly, microtiter plates (Greiner Bio-One, Frickenhausen, Germany) were coated with rabbit anti-hIgG or anti-hlgA or anti-hIgM antibody (Dako Cytomation, Glostrup, Denmark) by incubating for 3 h at 37°C and overnight at 4°C. The diluted supernatants were incubated for 2 h at 37°C; then, rabbit anti-hIgG or anti-hIgA or anti-hIgM antibodies conjugated to horseradish peroxidase (Dako) were added. The concentration of each isotype was extrapolated from the standard curve for each plate and, referring to CD19 and CD45 percentages, was expressed as ug/ml/I 0 6 CD19 positive cells.
Specific Pn polysaccharide IgM quantification
Specific IgM against serotype 14 of pneumococcal polysaccharides in the supernatant was measured by Cpolysaccharide (C-PS) adsorbed ELISA following the WHO instructions. The US standard reference serum lot 89-SF from the WHO International Laboratory for Biological Standards (NIBSC and Wyeth Lederle Vaccines) was used as a reference standard. ELISA was performed as previously described (22) . Briefly, microtiter plates were incubated with 2 ug/ml of 14Pn antigen for 5 h at 37°C and over night at 4°C. After 30 mins absorption of samples with 5 ug/ml of C-PS and 5 ug/ml of 22F, they were added to the wells and incubated for 2 h at 37°C. Standard reference serum was adsorbed only with C-PS. After washing, anti-human IgM HRP conjugate was added and the plates were incubated for 2 h at 37°C. After adding substrate solution and enzyme reaction stop, optical density was read at 492 nm. The anti-14Pn antibody concentration for each sample was calculated by extrapolating the optical density from the standard reference serum curve.
Statistical Analysis
Percentages of B-lymphocyte subsets and values of spontaneous and stimulated Ig production at different time-points were compared with those observed at birth using analysis of variance for repeated measures. A generalized estimating equation (GEE) was used to fit the linear regression models in order to investigate, in the whole cohort, the relationship between resting or stimulated Ig production by CD19+CD27+ cells (gaussian dependent variable) over the entire 6-month follow-up. GEE was used to take into account the panelled structure (in this case: the infants) of the data, for which a number of subsequent observations are measured (in this case: months), specifying the within-group correlation structure for panels (in this case: autocorrelation matrix of order I).
The Spearman rank-order test was used to calculate the correlation between B cell subsets and Pn-IgM. p<0.05 was considered statistically significant. All analyses were performed with STATA (StataCorp, College station, TX).
RESULTS
Distribution ofB-Lymphocyte subsets
The percentage of CD19+ B-lymphocytes in PBMC of the 74 enrolled neonates was measured at birth, 1, 3, and 6 months. The results demonstrated a significant increase in the percentage of Blymphocytes at 1, 3, and 6 months oflife, as compared with values at birth (p<0.001, respectively) ( Fig.  lA) . Flow-cytometry analysis also documented that CD19+B-lymphocytes, evaluated at all the abovementioned time-points, co-expressed the CD20 molecule.
The distribution of CD27 neglgD+ naive, as well as CD27+IgD+ and CD27+IgDne g memory Blymphocyte subsets, was evaluated at birth and at 1, 3, and 6 months in 29 out of 74 enrolled neonates. As expected, results documented a predominance of naive B-lymphocytes at all time-points evaluated (Fig. lB) , even though the percentage of this B-cell subset significantly decreased at 6 months when compared to birth values (p=0.009). Moreover, the percentages of CD27+IgD+ (Fig. 1C ) and CD27+IgDne g (Fig. ID) memory B-cells were very low at birth and significantly increased (p=0.02 and p<O.OOl, respectively) only at 6 months. However, the percentage of CD27+ memory B-lymphocytes at this time point (median: 2.5; range: 1.2-9.7) was three times lower than in 3-15-year-old children (median: 7.3, range: 0.4-16.3). A representative flow cytometric analysis of PBMC from subjects at different ages is reported in Fig. 2 .
Results of the circulating B-lymphocyte subset distribution could not be expressed as an absolute number since lymphocyte absolute numbers were not available for individuals included in the study.
In vitro Ig secretion
In vitro Ig-secretion was evaluated at birth and at 1, 3, and 6 months in the 74 enrolled neonates. We found a significant increase in stimulated IgG production at 6 months as compared to birth (p<O.OOl), while IgM and IgA secretion, either spontaneous or stimulated, did not significantly vary in the first 6 months of life, when compared with values observed at birth. Taken together, the results showed that both spontaneous and stimulated Ig-secretion was lower in neonates at 6 months of age than in 3-15-year-old children (p< 0.001) ( Table I) .
The amount of IgG, IgM as well as IgA secreted in vitro obtained at 6 months of age, positively correlated with the percentage of CD2r memory B cells either under resting (p=0.02, p=O.OOI and p=O.OOI, respectively) or under stimulated conditions (p=0.002, p=0.03 and p=0.004, respectively).
In vitro secretion ofanti-Pn IgM antibodies
Secretion of anti-Pn IgM antibodies was evaluated in culture supernatants after in vitro PBMC stimulation in 26 out of 74 enrolled neonates, at birth and at I, 3, and 6 months. The results reported in Fig.  3 , documented a significantly lower secretion of anti-Pn IgM antibodies at 6 months of age, as compared to the 22 older children (p=0.02 resting and p=0.04 stimulated condition).
On the other hand, in vitro anti-Pn IgM secreted under resting conditions, evaluated at 6 months was significantly higher compared with birth (p=0.006) while under stimulated conditions it resulted significantly higher as compared to the other time points (p=0.003, p= 0.01 and p=O.OI respectively).
At six months of age, a positive correlation between the number of CD2r memory Blymphocytes and amount of anti-Pn IgM antibodies secreted under stimulated conditions was observed (p=0.005).
DISCUSSION
Initially, the neonate immune system was considered immature or immunodeficient, subsequently it was considered capable ofmounting a mature response and the transitory neonatal immune deficiency was ascribed to low cell numbers (11) . Human neonates are highly susceptible to infection by a wide range of bacteria, viruses, protozoa, and fungi. This heightened susceptibility and the severe course of infection in early life can be attributed, at least in part, to a lack of pre-existing immunological memory and competent adaptive immunity.
Our results regarding the percentage of B cell subsets are in agreement with the above observation, considering that the number of CD27+ memory B cells progressively increases with age. This B lymphocyte subset is reportedly able to secrete in . vitro Ig when stimulated with anti-CD40 plus ILl 0, indeed we observed a progressive increase in IgG and IgM in vitro production with age, but levels were still lower than those found in older controls. Moreover, in vitro production positively correlates with the percentage of CD27+ cells both under resting and stimulated conditions independently of time.
It is well known that the total absolute lymphocyte number is increased at birth and remains high for up to 6 months as compared to older children (23) (24) (25) . Unfortunately, the lymphocyte absolute number was not available for neonates included in this study. Therefore, while we believe that the reported lower percentages of CD27+IgD+ observed in neonates could be compensated by the increased number of B cells reported at this age, we think it is unlikely that the very low percentage of CD27+IgDne g cells able to produce Ig, observed in neonates could be balanced by the higher B cell absolute number.
There are several cases in which mature responses have been reached in vivo after newborn and infant vaccination. For instance, immunization of newborns with BCG results in a response quantitatively similar to that observed in immunized adults (26) (27) , and both polio and hepatitis B vaccines, administered at birth induce strong antibody responses similar to those found in immune competent adults (28) (29) .
Our in vitro investigation established that neonatal B lymphocytes are able to produce Ig if adequately stimulated, but the production is lower when compared to controls indicating that the neonate 18 
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immune system is in the course of development.
One significant problem in infant immunity is the inability to mount an adequate and rapid response to T independent antigens (30) . It has been shown that the physiological and transient predisposition to pneumococcal infections in young children is associated with a lack of CD27+IgM+ memory cells and of serum anti-polysaccharide IgM (15) . Weller et al. (17) have shown that this B cell subset derives from the splenic marginal zone, moreover it has been reported that the immune system of a child is not capable of initiating a rapid secondary humoral immune response due to the absence of memory B cells in the spleen (31) . In the present study we quantified the natural antibody in vitro production in neonates by stimulating peripheral B cells with anti-CD40.
In vitro natural antibody levels correlate with the number of CD27+ cells, strengthening the finding of Carsetti et al (15) that these B cell subsets are responsible for natural antibody production. We found a very low amount of serum antipolysaccharide IgM from birth to 3 months, and only at 6 months did we observe significant differences comparing results obtained at birth, but these were In vitro anti-Pn IgM secreted under the resting condition, evaluated at 6 months was significantly higher when compared to values at birth (p=0.006) while under the stimulated condition they resulted significantly higher when compared to the other time points (p=0.003, p= 0.01 and p=O.OI respectively). Significantly lower secretion was observed at 6 months of age, compared to controls (p=0.02 for resting and p=0.04 for stimulated conditions). still lower than in older children.
Taken together, our results emphasize that the susceptibility and severe course of infection in the neonate can be attributed, at least in part, to the lack of pre-existing immunological memory and competent adaptive immunity. On the other hand, innate recognition of pathogens is the first step in inducing adaptive immunity and, even though the innate system is ontogenetically older than the adaptive system, we found a delay also in the innate immune response, characterized by the absence of natural antibody production, in early life.
